Kilroy Realty Corporation KRC
Composite 47/100; the shares have moved about 29% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Balance-sheet strength ranks 33/100 — a moderate mark against it.
Valuation ranks 60/100 — a slight point in its favour. Income ranks 60/100 — a slight point in its favour. Momentum ranks 50/100 — a slight point in its favour.
Balance-sheet strength ranks 33/100 — a moderate mark against it. Growth ranks 45/100 — a slight mark against it. Quality ranks 45/100 — a slight mark against it.
What the company does Kilroy Realty Corporation (KRC) is a U.S. REIT focused on office, life science, and mixed-use properties across high-growth markets like the Bay Area, Los Angeles, Seattle, and Austin. As of June 30 2026, its stabilized portfolio totaled 17.1 million square feet, 77% occupied and 81.5% leased, with an additional 608 residential units in San Diego at 95.6% occupancy.
Key financials KRC’s trailing twelve-month metrics include ROE 4%, ROA 2%, ROCE 4%, gross margin 66%, operating margin 23%, and net margin 20%. Revenue declined -0% and EPS fell -79% year-over-year. Leverage stands at debt/equity 0.86 and net debt/EBITDA 7.30, with interest coverage of 2.23 and current ratio 1.10.
Stock health Momentum shows 3m +22%, 6m +19%, and 12m +10%, while trading -7% below its 52-week high with RSI(14) 58. Dividend yield is 6% with a 151% payout ratio. Sidera’s overall score is 45/100 (weak quality, attractive valuation), with strength 29 and growth 19.
Price vs fair value KRC trades at a PREMIUM of 73.30% to our fair-value estimate and a PREMIUM of 0.64% to the 12-month analyst target. - BXP’s premium office leasing surge highlights competitive pressure in gateway markets (CRE Daily) - Q2 earnings call emphasized leasing progress and life-science demand (MarketBeat) - KRC topped Q2 FFO estimates, supporting near-term optimism (Zacks)
Looking forward Forward P/E of 56x and PEG of 1.8x reflect high expectations for occupancy recovery and rent growth, though consensus remains cautious given weak recent EPS trends. Analysts (n=14) see limited upside to the current price, implying valuation risk outweighs near-term operational improvements.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.